Abstract
Testicular neoplasms are rare tumors that account for only about 1% of all cancers occurring in males and have an average annual incidence of about 2.3 per 100,000 males in the English-speaking population [19, 32]. Nevertheless, these tumors have a dramatic impact because they occur predominantly in young men. Excluding leukemias and lymphomas, testicular tumors are the leading cause of lethal cancer in men from 25 to 34 years of age [57].
Chapter PDF
References
Abelev GI (1971) Alpha-protein in oncogenesis and its association with malignant tumors. Adv Cancer Res 14:295–358
Allaire F, Thieme E, Korst D (1961) Cancer chemotherapy with 5-fluorouracil alone and in combination with x-ray therapy. Cancer Chemother Rep 14:59–75
Anderson T, Waldmann TA, Javadpour N, Glatstein E (1979) Testicular germ cell neoplasms: Recent advances in diagnosis and therapy. Ann Intern Med 90:373–386
Ansari RH, Einhorn LH, Williams SD, Bond WH (1980) Short and long term platinum nephrotoxicity in patients with testicular cancer. PAACR-ASCO 21:135
Astrakhan V, Monul F (1976) Combined chemotherapy of testicular tumors resistant to sarcolysin. Vopr Onkol 13:87–90
Barski AA (1973) Diagnosis, staging and natural history of testicular tumors. Cancer 32:1202–1205
Batata MA Chu FCH, Hilaris BS, Whitmore WF, Grabstald H, Golbey R (1980) TNM staging of testis cancer. Int J Radiat Oncol Biol Phys 6:291–295
Batterman JJ, Delemarre JFM, Hart AAM, van Slooten EA, Tierie AH (1973) Testicular tumors: A retrospective study. Arch Chir Neere 25:457–469
Benjamin RS, Wiernick PH, Bachur NR (1973) Adriamycin-efficacy, safety and pharmacological basis of a single dose schedule. Cancer Chemother Rep 57:98
Blum RH, Carter SK, Agre K (1973) A clinical review of bleomycin — A new actineoplastic agent. Cancer 31:903–914
Boctor ZN, Kurohara SS, Badib AO (1969) Current results from therapy of testicular tumors. Cancer 24:8705
Boden G, Gibb R (1951) Radiotherapy and testicular neoplasms. Lancet 2:1195–1197
Bradfield JS, Hagen RO, Yterdal DO (1973) Carcinoma of the testis: An analysis of 104 patients with germinal tumors of the testis other than seminoma. Cancer 31:633–640
Buck, AS, Schamber DT, Maier JG, Lewis EL (1972) Supraclavicular node biopsy and malignant testicular tumors. J Urol 107:619–621
Buraey BT, Klatte EC (1980) Abdominal ultrasound and computed tomography in testicular cancer. In: Einhorn LH (ed) Testicular tumors, Masson, New York, p 83
Cavalli F, Klepp O, Renard J, Hansen HH, Alberto P (1980) A phase II study of oral VP-16 in patients with non-seminomatuus testicular cancer. PAACR-ASCO 21:137
Chebotareva L (1964) Late results of sarcolysin therapy in tumors of the testes. Acta UN Int Congr Cancer II: 380
Cheng E, Cvitkovic E, Wittes RE, Golbey RB (1968) Germ cell tumors (II) VAB II in metastatic testicular cancer. Cancer 42:2162–2168
Collins DM, Pugh RCB (1964) Classification and frequency of testicular tumors. Br J Urol [Suppl] 36:1–11
Costa G, Hreshchyshyn MM, Holland JF (1962) Initial clinical studies with vincristine. Cancer Chemother Rep 24:39–44
Cutler SJ, Young JL, Jr (eds) (1975) Third National Cancer Survey: Incidence data. Natl Cancer Inst Monogr 41
Devega SS, Silverman DT (1978) Cancer incidence and mortality trends in the United States 1935–1974. J Natl Cancer Inst 60:545–571
Dixon FJ, Moore RA (1952) Tumors of the male sex organs. In: Atlas of tumor pathology, vol 8, fasc 316, 32. Armed Forces Institute of Pathology, Washington DC, pp 48–127
Donohue RE, Pfister RR, Weigel JW, Stonington OG (1977) Supraclavicular node biopsy in testicular tumors. Urology 9:546–549
Dunnick NR (1979) Radiologic diagnosis in urologic cancer. In: Javadpour N (ed) Principles and management of urologic cancer. Williams and Williams, Baltimore, pp 127–167
Earle JE, Bagshäw MA, Kaplan HA (1971) Supervoltage radiation therapy of the testicular tumors. Am J Roentgerol Rad Ther Nucl Med 117:653–661
Einhorn LH (1978) Combination chemotherapy with cis-diammine dichloroplatinum, vinblastine and bleomycin in disseminated testicular cancer: An update. In: Carter SK, Crooke ST, Umezawa H (eds) Bleomycin: Current Status and New Developments Academic, New York
Einhorn LH (1980) The role of surgery in disseminated testicular cancer. PAACR-ASCO 21:159
Einhorn LH, Donahue JP (1977) Combination chemotherapy with cis-diammine dichloroplatinum, vinblastine and bleomycin in disseminated testicular cancer. Ann Intern Med 87:293–298
Einhorn LH, Donahue JP (1979) Combination chemotherapy in disseminated testicular cancer: the Indiana University experience. Semin Oncol 6:87–93
Einhorn LH, Williams SD (1980) The management of disseminated testicular cancer In: Einhorn LH (ed) Testicular tumors management and treatment. Masson, New York, pp 117–150
Ferber B, Handy VH, Gerhardt PR, Solomon J (1962) Cancer in New York state exclusive of New York City, 1941–1960. Albany, New York, Bureau of Cancer Control, New York State Department of Health
Friedman M (1950) Tumors of the testis and their treatment. In: Portman UV (ed) Clinical therapeutic radiology. Nelson, New York
Gitlin A, Boesman M (1967) Sites of serum alpha-fetoprotein synthesis in the human and in the rat. J Clin Invest 46:1010–1016
Golbey RB, Reynolds TF, Vurgrin D (1979) Chemotherapy of metastatic germ cell tumors. Semin Oncol 6:82–87
Gorzynski JG, Holland JC (1979) Psychological aspects of testicular cancer. Semin Oncol 6:1
Hayes D, Cvitkovie E, Golbey B, Scheiner E, Krakoff IH (1976) Amelioration of renal toxicity of high dose cis-platinum diammine dichloride (CPPD) by Mannitol-induced diuresis. PAACR-ASCO 17:169
Higby DJ, Wallace HJ, Albert D, Holland JF (1974) Diamminodichloroplatinum in the chemotherapy of testicular tumors. J Urol 112:100–104
Hyman GA, Ultmann JE, Habif DV (1962) Factors to be considered in the clinical evaluation of a new chemotherapeutic agent (5-fluorouraeil). Cancer Chemother Rep 16:397–399
Jacobs EM (1970) Combination chemotherapy of metastatic testicular germinal cell tumors and soft part sarcomas. Cancer 25:324–332
Jacobs EM, Johnson D, Wood DA (1966) Stage III metastatic malignant testicular tumors. Treatment with intermittent and combined chemotherapy. Cancer 19:1697–1704
Jacobs EM, Muggia FM (1980) Testicular cancer: risk factors and the role of adjuvant chemotherapy. Cancer 45:1782–1790
Javadpour N (1979) The value of biologic markers in diagnosis and treatment of testicular cancer. Semin Oncol 6:37–47
Kennedy B (1969) Mithramycin treatment in testicular neoplasms. Am Soc Clin Oncol Abstr 20
Kohn J (1979) The value of apparent half-life assay of alpha-fetoprotein in the management of testicular teratoma. In: Lehmann FG (ed) Careino-embryonic proteins: chemistry, biology, clinical applications, vol. II. New York, pp 383–386
Krikorian J, Daniels JR, Brown BW, Hu SJ (1978) Variables for predicting serious toxicity (vinblastine dose, performance status and prior therapeutic experience): Chemotherapy for metastatic testicular cancer with cis-dichlorodiammine platinum (II), vinblastine and bleomycin. Cancer Treat Rep 62:1455–1465
Lange PH, Hekmat K, Bosi G, Kennedy BJ, Fraky EE (1980) Accelerated growth of testicular cancer after cytoreductive surgery. Cancer 45:1498–1506
Li FR, Fraumeni JF (1972) Testicular cancers in children: epidemiologic characteristics. J Natl Cancer Inst 48:1575–1582
Li MC (1966) Management of choriocarcinoma and related tumors of uterus and testis. Med Clin North 45:661
Li MC, Whitmore WF, Golbey R, Grabstald H (1960) Effects of combined drug therapy on metastatic cancer of the testis. J Am Med Assoc 174:1291–1299
Lien HH, Kolbenstuedt A (1977) Phlebography, urography and lymphography in the diagnosis of metastatis from testicular tumors. Acta Radiol [Diagn] (Stockh) 18:177–185
Lynch DF, Richie JO (1980) Supraclavicular node biopsy in staging testis tumor. J Urol 123:39–40
Mackenzie A (1966) Chemotherapy of metastatic testic cancer: Results in 154 patients. Cancer 19:1369–1376
Mackenzie AR, Duruman N, Whitmore WF (1967) Mithramycin in metastatic urogenital cancer J Urol 98:116–119
Maier JG, Mittemeyer B (1977) Carcinomas of the testis. Cancer 39:981–986
Maier JG, Sulak MH (1973) Radiation therapy in malignant testis tumors. Part II Carcinoma. Cancer 32:1217–1226
McKay EN, Sellers HH (1966) A statistical review of malignant testicular tumors based on the experience of the Ontario Cancer Foundation Clinics, 1938 to 1961. Can Med Assoc J 94: 889–899
Mendelson D (1969) Combination chemotherapy of disseminated testicular Tumors. Proc Am Soc Clin Oncol Abstr 27
Merrin C (1976) A new method to prevent toxicity with high doses of cis-diammine platinum. PAACR-ASCO 17:243
Monfardini S, Bajetta E, Musumeci R, Bonadonna G (1972) Clinical use of adriamycin in advanced testicular cancer. J Urol 108:293–296
Moore C (1968) Triple chemotherapy in treatment of metastatic testicular neoplasms. J Urol 100:527–529
Morrison AS (1975) Some social and medical characteristics of army men with testicular cancer. Am J Epidemiol 104:511–516
Morrison AS (1976) Cryptorchidism, hernia, and cancer of the testis. J Natl Cancer Inst 56:731–733
Mostofi FK (1979) Comparison of various clinical and pathological classifications of tumors of the testes. Semin Oncol 6:26–30
Murphy WT (1967) Radiation therapy. Saunders, Philadelphia, pp 810–827
Nishi S (1970) Isolation and characterization of human fetal cypha-globulin from the sera of fetuses and a hepatoma patient. Cancer Res 30:2507–2513
Nitschke R, Sterling K, Land V, Komp D (1976) Cis-platinum in childhood malignancies. PAACR-ASCO 17:310
O’Bryan RM, Luce JK, Talley RW, Gottlieb JA, Bakel LH, Bonadonna G (1973) Phase II evaluation of adriamycin in human neoplasia. Cancer 32:1–8
Oliver RTD, Wrigley PFM, Malpas JS (1980) Gonadal function after bleomycin, vinblastine and cisplatinum therapy. PAACR-ASCO 21:426
Osieka R, Bruntsen U, Gallmeier WM (1976) Cis-diamminodichloroplatin (II) in der Behandlung therapieresistenter maligner Hodenteratome. Dtsch Med Wochenschr 101:191–195
Peckham MJ, McElwain TJ (1974) Radiotherapy of testicular tumors. Proc R Soc Med 67:400–404
Peckham MJ, McElwain TJ, Barret A, Hendry WF (1979) Combined management of malignant teratoma of the testis. Lancet 11:267–270
Percarpio B, Clements JC, McLeod DG, Sorgen SD, Cardinale FS (1979) Anaplastic semnoma — An analysis of 77 patients. Cancer 43:2510–2513
Petersen GR, Lee JAH (1972) Secular trends of malignant tumors of the testis in white males. J Natl Cancer Inst 49:339–354
Pitts N (1970) Clinical data accumulated by Pfizer for NDA for mithramycin. In: Carter SK, Friedman MA (eds) Proceedings of the chemotherapy conference on mithramycin: development and application. Cancer Therapy Evaluation Program, NCI, Bethesda, pp 33–44
Ream NW, Perlia CP, Wolter J, Taylor SG (1968) Mithramycin therapy in disseminated germinal testicular cancer. JAMA 204:1030–1036
Rozencweig M, von Hoff DD, Slavik M, Muggia FM (1977) Cis-diamminodichloropla- tinum (II) A new anticancer drug. Ann Intern Med 86: 803–812
Samson MK, Stephen RL, Rivkin S, Opipari M, Maloney T, Groppe CW, Fisher R (1979) Vinblastine, bleomycin and cis-dichlorodiammineplatinum (II) in disseminated testicular cancer: preliminary. Cancer Treat Rep 63:1663–1667
Samuels ML, Howe CD (1970) Vinblastine in the management of testicular cancer. Cancer 25:1009–1017
Samuels ML, Johnson DE, Holoye PY (1975) Continuous intravenous bleomycin therapy with vinblastine in stage III testicular neoplasia. Cancer Chemother Rep 59:563–570
Samuels ML, Lanzotti VJ, Holoye PY, Boyle LE, Smith TL, Johnson DE (1976) Combination chemotherapy in germinal cell tumors. Cancer Treat Rev 3:185–204
Samuels ML, Johnson DE, Brown B (1979) Velban plus continuous infusion bleomycin (VB-3) in stage HI advanced testicular cancer. In: Johnson DE, Samuels ML (eds) Cancer of the Genitourinary Tract. Raven, New York, p 159
Scardino PT, Cox HA, Waldmann TA (1977) The value of serum tumor markers in the staging and prognisis of germ cell tumors of the testis. J Urol 118:994–999
Schaner EG, Chang AE, Doppman ML, Conkle DM, Flye MW, Rosenberg SA (1978) Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules. AJR 131:51–54
Shaw RK, Bruner JA (1964) Clinical evaluation of vincristine. Cancer Chemother Rep 42:45–48
Silvay O, Yagoda A, Wittes R, Whitmore W, Golbey R (1973) Treatment of germ cell carcinomas with a combination of actinomycin D, vinblastine and bleomycin. PAACR-ASCO 14:68
Skinner DG (1977) Advances in the management of non-seminomatous germinal tumors of the testis. Br J Urol 49:553–560
Smart CR, Rochlin DB, Nah-M AM, Silva A, Wagner LD (1961) Clinical experience with vinblastine sulfate in squamous cell carcinoma and other malignancies. Cancer Chemother Rep 34:31–45
Smithers DW, Wallace ENK (1962) Radiotherapy in the treatment of patients with seminomas and teratomas of the testicle. Br J Urol 34:422–435
Snyder W, Rodensky P, Lieberman B (1964) Regression, relapse and regression of metastatic seminoma by cyclophosphamide. Cancer Chemother Rep 41:34–40
Sogani PC, Vugrin D, Whitmore WF, Bains M, Herr H, Golbey R (1980) Experience with combination chemotherapy and surgery in the management of advanced germ cell tumors. PAACR-ASCO 21:401
Solomon J, Steinfeld JL, Batemen JR (1967) Chemotherapy of germinal tumors. Cancer 20:747–750
Spigel SC, Coliman CA (1974) Vinblastine and bleomycin therapy for disseminated testicular tumors. Cancer Chemother Rep 58:213–216
Spigel SC, Stephens RL, Haas CD (1978) Chemotherapy of disseminated germinal tumors of the testis — comparison of vinblastine and bleomycin with vincristine, bleomycin and actinomycin D. Cancer Treat Rep 62:129–130
Staubitz WJ, Early KS, Magoss IV, Murphy GP (1973) Surgical management of non-seminomatous germinal tumors. Cancer 32:1200–1211
Staubitz WJ, Magoss IV, Grace JT, Schenk WG (1969) Surgical management of testis tumors. J Urol 101: 350–355
Steinfeld JL, Solomon J, Marsh AA, Hazen JG, Bateman JR (1966) Chemical therapy of patients with advanced metastatic germinal tumors. J Urol 96:933–940
Sturgeon JFG, Alison RE, Comisarow RH, Bergsagei DE (1980) Advanced non-seminomatous testicular tumors: maintenance chemotherapy is unnecessary. PAACR-ASCO 21:153
Sulak MH (1970) Classification of different pathologic types. J Am Med Assoc 213: 91–93
Tan C, Etcubanas E, Wollner N et al. (1973) Adriamycin, an antitumor antibiotic in the treatment of neoplastic disease. Cancer 32:9–17
Tan CT, Golbey RB, Yab CL, Wollner N, Hackethal CA, Murphy LM, Dargeon HW, Burchenal JH (1960) Clinical experiences with acinomycins D, KS2 and F1 (KS4). Ann. NY Acad Sci 898:426–444
Vaitukaitus JL, Braunsten GD, Ross GT (1972) A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol 113:751–758
van Derwerf-Messing B (1976) Radiotherapeutic treatment of testicular tumors. Int J Radiat Oncol Phys 1:235–248
Vogelzang NJ, Bosl GJ, Johnson K, Kennedy BJ (1980) Raynauds phenomenon following induction chemotherapy for testicular tumor. PAACR-ASCO 21:151
Vugrin D, Cvitkovic E, Whitmore WF, Golbey RB (1979) Adjuvant chemotherapy in resected non-seminomatous germ cell tumors of the testis: Stages I-II. Semin Oncol 6:94–99
Vugrin D, Dukeman M, Whitmore W, Golbey R (1980) VAB-6: Progress in chemotherapy of germ cell tumors. PAACR-ASCO 21:426
Waldmann TA, Mclntyre KR (1972) Serum alpha-fetoprotein levels in patients with ataxia-telengiectasia. Lancet 2:1112–1115
Wallace S, Jing B (1970) Lymphangiography: Diagnosis of nodal metastases form testicular malignancies. JAMA 213:94–96
Walsh PC, Kaufman JJ, Coulson WF, Goodwin WE (1971) Retroperitoneal lymphadn- ectomy for testicular tumors. JAMA 217:309–312
Whitelaw DM, Cowan DH, Cassidy EB, Patterson TA (1963) Clinical experience with vincristine. Cancer Chemother Rep 30:12–20
Whitmore W (1962) Some experience with retroperitoneal lymph node dissection and chemotherapy in the management of testis neoplasms. Br J Urol 34:436–447
Whitmore WF (1968) The treatment of germinal tumors of the testis. In: Cancer management. Lippencott, Philadelphia, p 347
Whitmore WF (1970) Germinal tumors of the testis. In: Proceedings of the sixth national cancer conference. Lippencott, Philadelphia, pp 219–245
Whitmore WF (1979) Surgical treatment of adult germ cell tumors. Semin Oncol 6:55–69
Williams SD, Einhorn LH (1980) Cisplatin chemotherapy of testicular cancer. In: Prestayko AW, Crooke ST, Carter SK (eds) Cisplatin current status and new developments. Academic, New York, pp 323–328
Williams SD, Einhorn LH (1980) VP-16–213: An active drug in germinal neoplasms. In: Einhorn LH (ed) Testicular tumors management and treatment. Masson, New York, pp 169–178
Williams SD, Einhorn LH (1980) Brain metastases in testicular cancer. In: Einhorn LH (ed) Testicular tumors management and treatment. Masson, New York, pp 179–184
Wilson W (1970) Chemotherapy of human solid tumors with 5-fluorouracil. Cancer 13:1230–1239
Wyatt JK, McAninch LN (1967) A chemotherapeutic approach to advanced testicular carcinoma. Can J Surg 10:421–426
Yarbro JW, Kennedy BJ (1967) A comparison of the rate of recovery from inhibition of RNA synthesis in mouse liver and transplantable glioma. Cancer Res 27: 1779–1782
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Carter, S.K. (1983). The Management of Testicular Cancer. In: Torti, F.M. (eds) Urologic Cancer: Chemotherapeutic Principles and Management. Recent Results in Cancer Research, vol 85. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81994-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-81994-0_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81996-4
Online ISBN: 978-3-642-81994-0
eBook Packages: Springer Book Archive